Gamunex-c 40 gram/400 ML vial 400ML
Ended Awarded
- Contract number
- SPE2DR26FG1DG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,430
Award facts
- Contract value 100% obligated
- $29,430.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $29,430.12 to AmerisourceBergen Drug Corp for the supply of Gamunex-C 40 gram/400 mL vials on November 17, 2025. This firm fixed-price delivery order, which has no set-aside designation, is scheduled for completion by December 9, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Gamunex-C is an intravenous immunoglobulin product used to treat primary immunodeficiency disorders and other immune-related conditions, making this procurement part of the federal government's broader medical supply chain supporting military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement valued through December 2026. The SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to support Defense Health Agency operations and other federal healthcare systems worldwide. AmerisourceBergen's position as a major pharmaceutical distributor and its successful competitive performance across multiple federal contracts demonstrate the company's capability to fulfill critical medical procurement requirements for the Department of Defense.
Quick answers
Who was awarded contract SPE2DR26FG1DG?
SPE2DR26FG1DG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26FG1DG worth?
The government has obligated $29,430 on SPE2DR26FG1DG.
Is contract SPE2DR26FG1DG an order under another contract?
Yes. SPE2DR26FG1DG is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG1DG competed?
The extent of competition for SPE2DR26FG1DG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award